By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272


SEARCH JOBS


Industry
Healthcare

Segment
Pharmaceuticals





Company News
Astellas Pharma Inc. (ALPMY) Release: Data Presented From Phase 2 Study Of Enzalutamide In Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer 12/15/2014 10:41:27 AM
Medivation, Inc. (MDVN) And Astellas Pharma Inc. (ALPMY) Phase 3 PREVAIL Trial Named Clinical Advance Of The Year By SCRIP 12/12/2014 11:04:46 AM
Astellas Pharma Inc. (ALPMY), Janssen Biotech Inc. (JNJ) To End Collaboration On RA Drug ASP015K 12/2/2014 8:13:35 AM
Ironwood Pharmaceuticals (IRWD) Earns $15 Million Milestone From Astellas Pharma Inc. (ALPMY) 11/20/2014 7:13:50 AM
Changing Tomorrow Day 2014 Marks Astellas Pharma Inc. (ALPMY)' Fifth Annual Global Service Initiative 11/4/2014 8:26:49 AM
Dana-Farber Cancer Institute And Astellas Pharma Inc. (ALPMY) Announce Research Collaboration 11/4/2014 7:21:32 AM
Astellas Pharma Inc. (ALPMY), Proteostasis Therapeutics, Inc. Forge $1.2 Billion Genetic Disease Drug Pact 11/4/2014 5:51:14 AM
FDA Grants Orphan Drug Designation To Astellas Pharma Inc. (ALPMY) For Isavuconazole For The Treatment Of Invasive Candidiasis 11/3/2014 8:43:33 AM
QIAGEN N.V. (QGEN) Announces Broad Agreement With Astellas Pharma Inc. (ALPMY) To Develop Companion Diagnostics 10/29/2014 7:32:23 AM
Astellas Pharma Inc. (ALPMY)'s XTANDI™ (Enzalutamide) Capsules Receive Positive CHMP Opinion For The Treatment Of Men With Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve 10/24/2014 10:58:35 AM
12345678910...
//-->